RESMED INC Cash And Cash Equivalents At Carrying Value

• RESMED INC showed an increase of +407.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2010: $540.00 million | Q4 2010: $616.20 million | Q1 2011: $671.70 million | Q3 2011: $610.06 million | Q4 2011: $723.23 million | Q1 2012: $776.07 million | Q3 2012: $890.63 million | Q4 2012: $958.28 million | Q1 2013: $1.01 billion | Q3 2013: $976.57 million | Q4 2013: $972.68 million | Q1 2014: $938.56 million | Q3 2014: $881.69 million | Q4 2014: $880.70 million | Q1 2015: $866.33 million | Q3 2015: $822.05 million | Q4 2015: $658.80 million | Q1 2016: $718.50 million | Q3 2016: $781.66 million | Q4 2016: $788.15 million | Q1 2017: $827.31 million | Q3 2017: $811.10 million | Q4 2017: $858.90 million | Q1 2018: $704.28 million | Q3 2018: $230.19 million | Q4 2018: $149.47 million | Q1 2019: $146.51 million | Q3 2019: $172.15 million | Q4 2019: $204.10 million | Q1 2020: $352.86 million | Q2 2020: $463.16 million | Q3 2020: $421.41 million | Q4 2020: $255.87 million | Q1 2021: $230.64 million | Q3 2021: $276.15 million | Q4 2021: $194.48 million | Q1 2022: $201.77 million | Q3 2022: $207.16 million | Q4 2022: $253.20 million | Q1 2023: $227.89 million | Q3 2023: $209.10 million | Q4 2023: $210.25 million | Q1 2024: $237.91 million | Q3 2024: $426.36 million | Q4 2024: $521.94 million | Q1 2025: $932.71 million | Q2 2025: $1.21 billion | Q3 2025: $1.38 billion | Q4 2025: $1.42 billion.
• Over the full 17 years of available data (2009 to 2025), RESMED INC's Cash And Cash Equivalents At Carrying Value has grown by 191.0%.
• Historical annual values: Fiscal year 2025: $1.21 billion | Fiscal year 2024: $238.36 million | Fiscal year 2023: $227.89 million | Fiscal year 2022: $273.71 million | Fiscal year 2021: $295.28 million | Fiscal year 2020: $463.16 million | Fiscal year 2019: $147.13 million | Fiscal year 2018: $188.70 million | Fiscal year 2017: $821.94 million | Fiscal year 2016: $731.43 million | Fiscal year 2015: $717.25 million | Fiscal year 2014: $905.73 million | Fiscal year 2013: $876.05 million | Fiscal year 2012: $809.54 million | Fiscal year 2011: $735.27 million | Fiscal year 2010: $488.78 million | Fiscal year 2009: $415.65 million.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026